Pharmaceutical

Filter

Current filters:

None

Popular Filters

6654 to 6678 of 7100 results

US ANDAs filed for generic Beyaz, Isentress and Epivir

12-01-2012

The US Food and Drug Administration says that Abbreviated New Drug Applications have been received by…

Anti-viralsBayerBeyazEpivirGenericsGlaxoSmithKlineIsentressMerck & CoPharmaceuticalRegulationReproductive

Negative NICE guidance for Sanofi prostate cancer drug

12-01-2012

The UK’s drug watchdog the National Institute for Health and Clinical Excellence (NICE), has today…

EuropeJevtanaOncologyPharmaceuticalPricingRegulationSanofi

Merck & Co out to lead in hepatitis C

12-01-2012

US drugs giant Merck & Co (NYSE: MRK) aims to become a leader in the hepatitis C space, the company’s…

Anti-viralsMerck & CoMergers & AcquisitionsPharmaceuticalResearch

Another historic low in US health spending growth

12-01-2012

US health care spending experienced historically low rates of growth in 2009 and 2010 according to the…

FinancialHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPricing

Threats to US biomedical industry viewed by CEOs

12-01-2012

Access to capital, a burdensome and uncertain regulatory environment and lack of innovation and productivity…

BiotechnologyFinancialNorth AmericaPharmaceuticalRegulationResearch

Nomura bearish on European pharmaceuticals

11-01-2012

With rich valuations driven by cyclical rotation towards all defensives, Nomura pharmaceutical analyst…

EuropeFinancialPharmaceuticalResearch

AstraZeneca links with IMS on real-world evidence

11-01-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a three-year collaboration agreement…

AstraZenecaEuropeHealthcarePharmaceuticalResearch

EMA opens public consultation on cancer drugs evaluation

11-01-2012

A public consultation on the revised guideline on the evaluation of human anticancer medicines has been…

BiotechnologyEuropeOncologyPharmaceuticalRegulation

2011 a bumper year for Pharma, Biotech and Generics M&A

11-01-2012

Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2011

11-01-2012

Details for the 129 M&A announcements recorded by The Pharma Letter are provided in the full table

BiotechGenericsMergers & AcquisitionsPharmaceutical

Another mega deal for FORMA Therapeutics

11-01-2012

Hot on the heels of its up to $815 million oncology-related deal with Boehringer Ingelheim (The Pharma…

BiotechnologyFORMA TherapeuticsJanssen BiotechJohnson & JohnsonLicensingOncologyPharmaceuticalResearch

FDA updates on obesity drug candidates

11-01-2012

There have been two pieces of positive news coming out of the US Food and Drug Administration this week…

Arena PharmaceuticalsEisailorcaserinLorquessMetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

Three new partnerships for Sanofi

10-01-2012

French drug major Sanofi (Euronext: SAN) had a busy day yesterday, announcing three different collaboration…

DiabetesFoundation MedicineLicensingOncologyPharmaceuticalResearchSanofiWarp Drive Bio

Merck & Co selects Idera vaccine candidates

10-01-2012

Idera Pharmaceuticals (Nasdaq: IDRA) says that US drugs giant that Merck & Co (NYSE: MRK) has selected…

Idera PharmaceuticalsLicensingMerck & CoPharmaceuticalResearchVaccines

Shire gets US Rights to Resolor

10-01-2012

Ireland-headquartered specialty biopharma firm Shire (LSE: SHP) says that it has acquired the rights…

Gastro-intestinalsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResolorShire

EC backs continued use of pioglitazone drugs for diabetes

10-01-2012

Japan’s largest drugmaker, Takeda Pharmaceutical (TYO 4502) said yesterday that the European Commission…

ActosDiabetesEuropePharmaceuticalPioglitazoneRegulationTakeda Pharmaceuticals

Why personalized medicine holds promise in diabetes

10-01-2012

With the trend in healthcare moving toward an era of personalized medicine, there is much anticipation…

DiabetesPharmaceuticalResearch

GSK and Theravance to file COPD/asthma drug

10-01-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) and partner USA-based Theravance (Nasdaq: THRX), in which…

GlaxoSmithKlinePharmaceuticalRegulationRelovairResearchRespiratory and PulmonaryTheravance

Xenon in $646 million deal with Roche unit

10-01-2012

Canada based Xenon Pharmaceuticals, a privately-owned, clinical genetics-based drug discovery and development…

BiotechnologyGenentechLicensingNeurologicalPharmaceuticalResearchRocheXenon Pharmaceuticals

NICE calls for more data on Xarelto; Bayer files for added indication

10-01-2012

In preliminary recommendations published yesterday (January 9) the UK’s drugs watchdog the National…

BayerCardio-vascularEuropePharmaceuticalRegulationXarelto

LEO Pharma in over $300 million deal for psoriasis therapy

10-01-2012

Privately-held Danish drugmaker LEO Pharma A/S has signed a multi-million dollar in-licensing deal with…

BiotechnologyDermatologicalsLEO PharmaLicensingPharmaceuticalVirobay

Added benefit of Trajenta not proven, says German agency

10-01-2012

In an early benefit assessment under Germany’s "Act on the Reform of the Market for Medicinal Products”…

Boehringer IngelheimDiabetesEli LillyEuropePharmaceuticalRegulationTrajenta

Vertex plans for Kalydeco launch

09-01-2012

US drugmaker Vertex Pharmaceuticals (Nasdaq: VRTX) announced its 2012 business objectives in conjunction…

Anti-viralsIncivekKalydecoPharmaceuticalRare diseasesRegulationResearchVertex

Ownership change for BioLigands ApS

09-01-2012

The founding shareholders in BioLigands ApS together with UK based biotech Bridge BioResearch have taken…

BioLigandsMergers & AcquisitionsPharmaceutical

6654 to 6678 of 7100 results

Back to top